Novo Nordisk shares slide after guidance disappoints investors
U.S.-traded shares of Novo Nordisk dropped on Tuesday after the Danish drugmaker released guidance that appeared to disappoint investors. CNBC’s Annika Kim Constantino reports.
U.S.-traded shares of Novo Nordisk dropped on Tuesday after the Danish drugmaker released guidance that appeared to disappoint investors. CNBC’s Annika Kim Constantino reports.
